Skip to main content
AGP Limited logo

AGP Limited — Investor Relations & Filings

Ticker · AGP ISIN · PK0113801010 PSX Manufacturing
Open in API
Filings indexed 167 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country PK Pakistan
Listing PSX AGP

About AGP Limited

https://agp.com.pk/

AGP Limited is a pharmaceutical company established in 1989. It specializes in the manufacturing, marketing, and distribution of a broad range of pharmaceutical and healthcare products. The company's portfolio includes internal medicine, gynaecology, pediatrics, orthopedic, cardiometabolic, and neuropsychiatry products. AGP Limited focuses on niche products, often manufactured and marketed under licensing arrangements with reputable European and American multinational pharmaceutical companies. The company operates with a strong commitment to quality, implementing an independent Quality Management System to ensure the safety, effectiveness, and high standards of its products for both domestic and export markets.

Recent filings

Filing Released Lang Actions
Presentation of Corporate Briefing Session
Regulatory Filings
2026-05-19 English
Notice of Corporate Briefing Session
Regulatory Filings Classification · 72% confidence The document is a notice sent to the stock exchange announcing a Corporate Briefing Session (CBS) to discuss the annual financial performance for the year ended December 31, 2025. It does not contain the actual financial report or detailed presentation slides; rather, it is a regulatory announcement of an upcoming investor briefing. It falls into the catch-all category for miscellaneous regulatory filings that don’t neatly fit elsewhere. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-18 English
ADJOURNMENT OF BOARD MEETING OTHER THAN FINANCIAL RESULTS
Regulatory Filings Classification · 85% confidence The document is a formal notice to the stock exchange informing about the adjournment of the board meeting and continuation of the closed period. It does not present financial results, nor does it announce changes in board composition or senior management. It is a general regulatory announcement filed with the exchange, falling under the catch-all category for miscellaneous regulatory filings.
2026-05-18 English
Board Meeting In Progress
Regulatory Filings Classification · 87% confidence The document is a brief notice to the stock exchange that a Board of Directors meeting is in progress, with no substantive content on financial results or changes, and no actual report attached. It is a general regulatory announcement and does not fit any specific category like earnings release, proxy materials, or management change disclosures. It is therefore classified as a Regulatory Filing (fallback category).
2026-05-15 English
Material Information
Transaction in Own Shares Classification · 92% confidence The document is an official intimation under stock exchange regulations detailing the company’s purchase (buy-back) of its own shares, including date, number of shares, and average rate. This matches the definition for ‘Transaction in Own Shares’ (share repurchase).
2026-05-11 English
Board Meeting Other Than Financial Results
Regulatory Filings Classification · 85% confidence The document is a regulatory notice informing the stock exchange of an upcoming board meeting (other than financial results) and a closed trading period. It contains no financial statements or results, nor changes to the board membership, and is not an AGM packet or management discussion. It is a general compliance announcement to the exchange, so it falls under the fallback “Regulatory Filings” category (RNS).
2026-05-08 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.